In the face of chronic disease, DTx have the opportunity to provide a lifeline to patients.
Joel Morse
Advertisement
CEO, Curavit Clinical Research
Articles by Joel Morse
How DCTs can impact pharmaceutical companies exploring DTx combination products and standalone DTx studies.
Advertisement
Latest Updated Articles
How Healthcare Economics Outcomes Evidence Can Pave the Way for Digital TherapeuticsPublished: December 21st 2023 | Updated:
Digital Therapeutics and Decentralized Trials: A Match Made in ClinicalPublished: April 13th 2022 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Applied Clinical Trials' 2025 State of the Industry Survey
2
The Confidence Trap in Clinical Trials: When Knowing Just Enough Becomes Dangerous
3
ACT Brief Weekly Recap: Clinical Research Faces Funding Strain, Data Evolution, and a Shift in Outsourcing Models
4
Do Phase II Protocol Learnings Help Simplify Phase III Protocol Designs?
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
